Can't wait till it is Celgene's turn to be the one bought. I hope you are treated exactly as you treated others.
They all kind of make Wall Street scratch their head and go hmmmmmm?? What were they thinking??? Pharmion- Vidaza going generic Gloucester- Istodax uptake is so slow the sales numbers are not in quarterly earnings Abraxis- Selling against two generic taxanes?? Even with the latest price increase for Abraxane numbers will trend down.
At Celgene, Bigger Isn’t Better: Why Acquisitions Are Ruining a Once Great Company. This is from a Teva article today, but it applies to Celgene. The once great company Celgene now has more products, but still only one growth driver, Revlimid.